ABT
Price
$117.25
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
Earnings call today
CNMD
Price
$64.59
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
14 days until earnings call
Ad is loading...

ABT vs CNMD

Header iconABT vs CNMD Comparison
Open Charts ABT vs CNMDBanner chart's image
Abbott Laboratories
Price$117.25
Change-$0.00 (-0.00%)
Volume$3.67M
CapitalizationN/A
CONMED
Price$64.59
Change-$0.00 (-0.00%)
Volume$462.82K
CapitalizationN/A
View a ticker or compare two or three
ABT vs CNMD Comparison Chart
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CNMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABT vs. CNMD commentary
Oct 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and CNMD is a Sell.

COMPARISON
Comparison
Oct 16, 2024
Stock price -- (ABT: $117.25 vs. CNMD: $64.59)
Brand notoriety: ABT: Notable vs. CNMD: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 80% vs. CNMD: 122%
Market capitalization -- ABT: $194.5B vs. CNMD: $2.43B
ABT [@Medical Specialties] is valued at $194.5B. CNMD’s [@Medical Specialties] market capitalization is $2.43B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 1 FA rating(s) are green whileCNMD’s FA Score has 1 green FA rating(s).

  • ABT’s FA Score: 1 green, 4 red.
  • CNMD’s FA Score: 1 green, 4 red.
According to our system of comparison, ABT is a better buy in the long-term than CNMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 5 TA indicator(s) are bullish while CNMD’s TA Score has 4 bullish TA indicator(s).

  • ABT’s TA Score: 5 bullish, 4 bearish.
  • CNMD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABT is a better buy in the short-term than CNMD.

Price Growth

ABT (@Medical Specialties) experienced а +3.43% price change this week, while CNMD (@Medical Specialties) price change was +0.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

ABT is expected to report earnings on Jan 22, 2025.

CNMD is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than CNMD($2.43B). CNMD has higher P/E ratio than ABT: CNMD (38.71) vs ABT (34.38). ABT YTD gains are higher at: 8.139 vs. CNMD (-40.561). ABT has higher annual earnings (EBITDA): 10.5B vs. CNMD (192M). ABT has more cash in the bank: 7.28B vs. CNMD (24.3M). CNMD has less debt than ABT: CNMD (974M) vs ABT (15.6B). ABT has higher revenues than CNMD: ABT (40.1B) vs CNMD (1.25B).
ABTCNMDABT / CNMD
Capitalization194B2.43B7,980%
EBITDA10.5B192M5,469%
Gain YTD8.139-40.561-20%
P/E Ratio34.3838.7189%
Revenue40.1B1.25B3,221%
Total Cash7.28B24.3M29,955%
Total Debt15.6B974M1,602%
FUNDAMENTALS RATINGS
ABT vs CNMD: Fundamental Ratings
ABT
CNMD
OUTLOOK RATING
1..100
952
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
36100
SMR RATING
1..100
5864
PRICE GROWTH RATING
1..100
4880
P/E GROWTH RATING
1..100
5888
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (12) in the Medical Specialties industry is in the same range as CNMD (12). This means that ABT’s stock grew similarly to CNMD’s over the last 12 months.

ABT's Profit vs Risk Rating (36) in the Medical Specialties industry is somewhat better than the same rating for CNMD (100). This means that ABT’s stock grew somewhat faster than CNMD’s over the last 12 months.

ABT's SMR Rating (58) in the Medical Specialties industry is in the same range as CNMD (64). This means that ABT’s stock grew similarly to CNMD’s over the last 12 months.

ABT's Price Growth Rating (48) in the Medical Specialties industry is in the same range as CNMD (80). This means that ABT’s stock grew similarly to CNMD’s over the last 12 months.

ABT's P/E Growth Rating (58) in the Medical Specialties industry is in the same range as CNMD (88). This means that ABT’s stock grew similarly to CNMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTCNMD
RSI
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
37%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 21 days ago
53%
Bearish Trend 6 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ABT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CNMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X66046.1250003194.750000
+5.08%
Bitcoin cryptocurrency
GME21.330.50
+2.40%
GameStop Corp
AAPL231.403.85
+1.69%
Apple
SPY584.324.74
+0.82%
SPDR® S&P 500® ETF Trust
TSLA219.161.36
+0.62%
Tesla

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
+0.97%
MDT - ABT
49%
Loosely correlated
+0.73%
SYK - ABT
47%
Loosely correlated
+1.16%
BSX - ABT
43%
Loosely correlated
+0.52%
BAX - ABT
42%
Loosely correlated
+1.01%
ZBH - ABT
42%
Loosely correlated
+1.29%
More

CNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with MYGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then MYGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNMD
1D Price
Change %
CNMD100%
+0.89%
MYGN - CNMD
45%
Loosely correlated
+4.28%
FLGT - CNMD
38%
Loosely correlated
+2.47%
ANGO - CNMD
38%
Loosely correlated
+0.78%
ATRC - CNMD
38%
Loosely correlated
-0.79%
AVNS - CNMD
38%
Loosely correlated
+0.35%
More